Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 20/20 | 0.78 |
| ▸ | JAK2 | O60674 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | HRH2 | P25021 | 1/20 | 0.65 |
| ▸ | CDK7 | P50613 | 1/20 | 0.65 |
| ▸ | CD69 | Q07108 | 1/20 | 0.65 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.65 |
| ▸ | MAP3K19 | Q56UN5 | 1/20 | 0.65 |
| ▸ | CDKL2 | Q92772 | 1/20 | 0.65 |
| ▸ | RIOK1 | Q9BRS2 | 1/20 | 0.65 |
| ▸ | RIOK2 | Q9BVS4 | 1/20 | 0.65 |
| ▸ | BMP2K | Q9NSY1 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16794230 | 1.00 | BTK (0.78) | BTKJAK2CYP3A4HRH2CDK7 | |
| SCHEMBL16794091 | 0.89 | BTK (0.83) | BTKJAK2CYP3A4HRH2CDK7 | |
| SCHEMBL16794089 | 0.89 | BTK (0.83) | BTKJAK2CYP3A4HRH2CDK7 | |
| SCHEMBL16794193 | 0.89 | BTK (0.83) | BTKJAK2CYP3A4HRH2CDK7 | |
| SCHEMBL19557880 | 0.89 | BTK (0.83) | BTKJAK2CYP3A4HRH2CDK7 | |
| SCHEMBL18183977 | 0.88 | BTK (0.76) | BTKJAK2CYP3A4HRH2CDK7 | |
| SCHEMBL29676702 | 0.85 | BTK (0.71) | BTKJAK2CYP3A4HRH2CDK7 | |
| SCHEMBL16794389 | 0.85 | BTK (0.74) | BTKJAK2CYP3A4HRH2CDK7 | |
| SCHEMBL16794136 | 0.85 | BTK (0.62) | BTKJAK2CYP3A4HRH2CDK7 | |
| SCHEMBL29676631 | 0.84 | BTK (0.77) | BTKJAK2CYP3A4HRH2CDK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109096274-B | Biaryl compounds useful in the treatment of human oncological, neurological and immunological diseases | 比奥根MA公司 | 2022-07-01 | — | — | CN | disclosed |